The health and human services secretary is shrinking staff at health agencies and reshaping the mission of his department to ...

The annual meeting of the American Society of Clinical Oncology was held from May 31 to June 3 in Chicago and hosted more ...

ASCO 2025 delivered pivotal updates. In this article, we discuss 8 of the more interesting abstracts from an investment ...

Some men might also inherit a family cancer syndrome that increases their cancer risk. For instance, Lynch syndrome can put ...

Dietmar Berger, M.D., Ph.D., joined Gilead Sciences as chief medical of | Dietmar Berger became Gilead Sciences’ new chief ...

ASCO Data Shows New Therapy Delays Breast Cancer Progression and May Improve Quality of Life for Women with Hormone ...

After two years of quietly shifting its medical affairs and commercial strategy units under one roof, Astellas is entering a ...

Patient with a grade 4, IDH-mutant, MGMT-methylated glioma remains alive and progression-free for four years after receiving ...

MEDSIR announces positive results from TUXEDO-3 trial of patritumab deruxtecan in patients with active brain metastases and leptomeningeal disease: Chicago Monday, June 9, 2025, 1 ...

Chinese shares trading in Hong Kong entered a bull market on Monday, as planned talks between the US and China fueled a wider ...

BISSELL Pet Foundation proudly announces a historic milestone: 1 million pets impacted through its national rescue, adoption, transport, and spay/neuter initiatives. Since its founding in 2011 by ...

The FDA has granted de novo authorization to CLAIRITY BREAST, a platform that uses AI to help predict a woman's risk of breast cancer.